Patents
Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
12/2000
12/12/2000US6159393 Electrooptical liquid-crystal display containing a liquid-crystalline medium
12/12/2000US6159352 Process for the electrochemical synthesis of N-acetylcysteine from cystine
12/12/2000CA2167397C Indoles
12/12/2000CA2041305C Process for the resolution of 3-(4-substituted-phenyl)-glycidic acid derivatives
12/12/2000CA2036413C Hiv protease inhibitors
12/07/2000WO2000073796A2 Ligand-anchor conjugates for producing a biosensor layer
12/07/2000WO2000073289A1 Alpha-phenyl-beta-ketosulfone
12/07/2000WO2000073266A1 Novel antioxidants, preparation methods and uses
12/07/2000WO2000073265A1 Sulfur-containing thyroxane derivatives and their use as hair growth promotors
12/07/2000WO2000073264A1 Cell proliferation inhibitors
12/07/2000WO2000073258A1 Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same
12/07/2000WO1999027005A3 Oxygen scavenging hydrotalcite and compositions containing same
12/07/2000CA2375667A1 Sulfur-containing thyroxane derivatives and their use as hair growth promotors
12/07/2000CA2375348A1 Novel antioxidants, preparation methods and uses
12/07/2000CA2375120A1 Bioactive sensors
12/07/2000CA2371092A1 Cell proliferation inhibitors
12/06/2000EP1057808A2 Sulfur-containing unsaturated carboxylate compound and its use
12/06/2000EP1056770A1 Novel disulfides and thiol compounds
12/06/2000EP1056734A2 Substituted alxoxycarbonyl compounds
12/06/2000EP1056717A1 Arylphenyl-substituted cyclic keto-enols
12/06/2000EP1056714A1 Phenylalanine derivatives as inhibitors of alpha4 integrins
12/06/2000EP1056704A1 Antitumor agents
12/06/2000CN1275981A Novel pharmaceutically active compounds, their preparation and use as ECE-inhibitors
12/05/2000US6156908 Cyclizing a 3-amino-2-oxoamino-5-methylsulfonium compound to for 3-amino-2-oxo-pyrrolidines as an end product
12/05/2000US6156902 Bis-o-amino (thio) phenols, and their preparation
12/05/2000US6156788 Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
12/05/2000US6156774 Beta-thiopropionyl-amino acid derivatives and their use as beta-lactamase inhibitors
12/05/2000US6156750 Bioactive bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
12/05/2000US6156741 Nervous system disorders
12/05/2000US6156163 Reactant, compound and process for the perfluoroalkylation of the nucleophile, and the derivatives obtained
12/04/2000WO2000075103A1 SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES AS AGONISTS TO HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) $g(a)
11/2000
11/30/2000WO2000071785A2 2-cylcoalkylcarbonylcyclohexane-1,3-dione derivatives as herbicides
11/30/2000WO2000071520A2 Aryl substituted alkylamines capable of activating nicotinic cholinergic receptors
11/30/2000WO2000071514A1 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS
11/30/2000WO2000071500A1 Halogen compounds
11/30/2000DE19924668A1 Substituierte alpha-Phenyl-beta-Ketosulfone Substituted alpha-phenyl-beta-ketosulfones
11/30/2000DE19924606A1 Ligand-Anker-Konjugate The ligand-anchor conjugates
11/30/2000CA2373789A1 Aryl substituted alkylamines capable of activating nicotinic cholinergic receptors
11/30/2000CA2373577A1 .alpha.-amino-.beta.-sulfonyl hydroxamic acid compounds
11/29/2000EP1055667A2 Mercapto alcohols as flavouring compounds
11/29/2000EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
11/29/2000EP1054857A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/29/2000CN1275077A Process to make chiral compound
11/29/2000CN1274717A Prepn. of methionine
11/28/2000US6153787 Intermediates for making heterocycles useful as COX-2 inhibitors
11/28/2000US6153650 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammation, and gastrointestinal damage.
11/28/2000US6153604 Treating disease of nervous system in which pathophysiology of disorder involves excessive excitation of nerve cells by agonists of nmda receptors, comprising administering to guanidine derivative
11/28/2000CA2310480A1 Flavor compounds
11/23/2000WO2000069810A1 Glucagon antagonists/inverse agonists
11/23/2000WO2000069800A2 Process for preparing ketones or aldehydes
11/23/2000DE19922934A1 New 5,5-dihalo- or 4,5,5-trihalo-4-pentenoic acid derivatives, useful as bactericides, fungicides, insecticides, acaricides and nematocides, especially plant fungicides
11/23/2000CA2373892A1 Glucagon antagonists/inverse agonists
11/22/2000EP1054000A1 Process for producing optically active cysteine derivatives
11/22/2000EP1053225A1 Process for the preparation of s-alkylcysteines
11/22/2000EP1053224A1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
11/22/2000EP1052984A1 Antibacterial agents
11/22/2000EP0827502B1 Methadone derivatives and protein and polypeptide methadone derivative conjugates and labels
11/22/2000CN1273969A Process for extracting alliin from garlic
11/22/2000CN1273967A Novel substituted dimeric compounds, its preparing process and medicinal compsns. containing same
11/21/2000US6150567 Reacting carbonyl compound with organoaluminum compound to form an alcohol compound
11/21/2000US6150563 Comprising aliphatic alkanal, water tartaric acid which forms complex with metal impurities to improve storage stability; oxidation resistance
11/21/2000US6150557 Compounds
11/21/2000US6150530 Amidation of amine with acid
11/21/2000US6150397 5-aroylnaphthalene derivatives as anti-inflammatory agents
11/21/2000US6150394 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
11/21/2000US6150042 Material for organoelectro-luminescence device and use thereof
11/21/2000CA2083639C Substituted phenyl phenol leukotriene antagonists
11/16/2000WO2000068218A1 Novel photoinitiators and their applications
11/16/2000WO2000068189A1 Alkylated fluorochemical oligomers and use thereof
11/16/2000DE19919336A1 Hydrolysis of thiazolidine derivative using acidic cation exchanger, giving 2-aminomercaptan derivative, e.g. cysteine or penicillamine, and carbonyl compound in high yield and purity
11/15/2000EP1052255A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics.
11/15/2000EP1051143A2 Oxidizing hair coloring agents containing 2,5-diamino-1-phenylbenzene derivatives and novel 2,5-diamino-1-phenylbenzene derivatives
11/15/2000CN1273244A Method for preparing cyclic thioamide compound
11/15/2000CN1273239A (Poly) thia acetylenic acid and it derivative, composite containing them and its application
11/15/2000CN1058498C Glycolipid analogs
11/14/2000US6147257 Process for the preparation of S-alkylcysteines
11/14/2000US6147250 Treating diseases mediated by vascular cell adhesion molecule-1, including cardiovascular and inflammatory diseases; succinobucol
11/14/2000US6147116 Polyaromatic antiviral compositions
11/14/2000US6147115 Antitumor compositions and methods of treatment
11/14/2000US6147114 Highly water-soluble metalloproteinase inhibitors
11/14/2000US6147063 Therapeutic substituted guanidines
11/14/2000US6146612 Method for recovering sulfuric acid from sulfate salts
11/14/2000CA1341138C Fluorine-containing chiral smectic liquid crystals
11/09/2000WO2000066545A1 6-[[(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof
11/09/2000WO2000066537A1 Spect imaging agents for serotonin transporters
11/09/2000WO2000066528A2 Quinones for treatment of diseases
11/09/2000WO2000066524A1 D-mannitol derivatives as hiv aspartyl protease inhibitors
11/09/2000WO2000066104A2 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000WO2000065913A1 Sulfonamide derivatives
11/09/2000CA2372672A1 D-mannitol derivatives as hiv aspartyl protease inhibitors
11/09/2000CA2372611A1 Quinones for treatment of diseases
11/09/2000CA2372481A1 Spect imaging agents for serotonin transporters
11/09/2000CA2372387A1 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000CA2371284A1 6-¬¬(aryl and heteroaryl)oxy| methyl|naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof
11/09/2000CA2371104A1 Sulfonamide derivatives
11/08/2000EP1050525A1 Substances capable of inducing apoptosis
11/08/2000EP1049793A2 Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
11/08/2000EP1049664A1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
11/08/2000EP1049663A1 Organic nitrile derivatives and their use as pesticides
11/08/2000EP1049662A1 Inhibitors of alpha4 mediated cell adhesion